Welcure Drugs & Pharmaceuticals Ltd Q2 Results
- BSE: 524661
- NSE: -
- ISIN: INE331C01025
- Sector: Biotechnology & Drugs
BSE
0.30
-0.01 (-3.23%)
-0.01 (-3.23%)Volume3.79 M
Updated: Tue 12 May, 2026 | 12:17:35
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Welcure Drugs & Pharmaceuticals Ltd Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 54.26 | 268.78 | -79.81% | 22.71 | 138.90% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.01 | -14.29% |
| Operating Income | 11.36 | 31.14 | -63.50% | 1.84 | 518.22% |
| Net Income | 8.50 | 23.30 | -63.50% | 1.84 | 362.64% |
| Other Operating Expenses Total | 0.11 | 0.02 | 388.89% | 2.11 | -94.78% |
| Net Income Before Taxes | 11.36 | 31.14 | -63.50% | 1.84 | 518.23% |
| Total Revenue | 65.62 | 299.91 | -78.12% | 24.55 | 167.31% |
| Selling/ General/ Admin Expenses Total | 0.01 | 0.03 | -57.89% | 0.10 | -85.98% |
| Diluted Normalized EPS | 0.07 | 0.19 | -63.29% | 0.12 | -44.14% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
- Welcure Drugs & Pharmaceuticals Ltd share price
- Welcure Drugs & Pharmaceuticals Ltd Profit Loss
- Welcure Drugs & Pharmaceuticals Ltd Balance Sheet
- Welcure Drugs & Pharmaceuticals Ltd Cashflow
- Welcure Drugs & Pharmaceuticals Ltd Q1 Results
- Welcure Drugs & Pharmaceuticals Ltd Q3 Results
- Welcure Drugs & Pharmaceuticals Ltd Q4 Results
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.